Dialysis disequilibrium syndrome: Difference between revisions

No edit summary
No edit summary
Line 6: Line 6:
**Post-dialysis urea in CSF higher, setting up osmotic gradient for water into CNS
**Post-dialysis urea in CSF higher, setting up osmotic gradient for water into CNS
**More uremic patients pre-dialysis at higher risk
**More uremic patients pre-dialysis at higher risk
*Characterized by neurological symptoms that is thought to be secondary to cerebral edema affecting dialysis patients
*Tends to occur in patients who are initially started on dialysis, particularly with high initial BUN
*Symptoms are thought to be secondary to the development of cerebral edema possibly due to urea removal during dialysis and from a decreased in pH in the cerebral intracelluar environment


==Clinical Features==
==Clinical Features==
Line 13: Line 18:
*Restlessness
*Restlessness
*Can progress to seizure, coma & death <ref name="DDS">Zepeda-orozco D. et al. Dialysis disequilibrium syndrome. Pediatr Nephrol. 2012;27(12):2205-11.[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491204/ Pubmed]</ref>
*Can progress to seizure, coma & death <ref name="DDS">Zepeda-orozco D. et al. Dialysis disequilibrium syndrome. Pediatr Nephrol. 2012;27(12):2205-11.[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491204/ Pubmed]</ref>
*Signs and symptoms develop during or after dialysis or during renal replacement therapy, usually self limited  but can occasionally progress
*Headache
*Nausea
*Visual disturbances
*Asterixis
*Altered mental staus
*Seizures
*Coma
*Muscle Cramps


==Differential Diagnosis==
==Differential Diagnosis==
Line 27: Line 44:
*[[Malignant hypertension]]<ref name="DDS"></ref><ref>Mahoney CA. et al. Uremic encephalopathies: clinical, biochemical, and experimental features. Am J Kidney Dis. 1982;2(3):324-36. [http://www.ncbi.nlm.nih.gov/pubmed/6756130 Pubmed]</ref>
*[[Malignant hypertension]]<ref name="DDS"></ref><ref>Mahoney CA. et al. Uremic encephalopathies: clinical, biochemical, and experimental features. Am J Kidney Dis. 1982;2(3):324-36. [http://www.ncbi.nlm.nih.gov/pubmed/6756130 Pubmed]</ref>
{{Dialysis complications DDX}}
{{Dialysis complications DDX}}
===Other===
*[[Hypoglycemia]]
*[[Hyponatremia]]
*[[Hypocalcemia]]
*[[Uremia]]
*Intracranial Bleed
*[[Hypertensive Emergency]]
*[[Stroke]]
*Supratheurapeutic Medication Effects
*PRES
==Evaluation==
*Clinical Diagonosis
*Bedside Glucose
*CBC
*Chem-10
*Liver Panel
*CT Brain


==Workup==
==Workup==
*Diagnosis suggested by development of neurologic symptoms associated with dialysis, however DDS is a diagnosis of exclusion (rule out [[SDH]], [[CVA]]).
*Diagnosis suggested by development of neurologic symptoms associated with dialysis, however DDS is a diagnosis of exclusion (rule out [[SDH]], [[CVA]]).


==Management==
==Management==
Line 46: Line 84:
*Symptoms are self-limiting and typically resolve within several hours
*Symptoms are self-limiting and typically resolve within several hours


==See Also==
*[[Dialysis complications]]
==References==
<references/>
[[Category:Renal]]
==Background==
*Characterized by neurological symptoms that is thought to be secondary to cerebral edema affecting dialysis patients
*Tends to occur in patients who are initially started on dialysis, particularly with high initial BUN
*Symptoms are thought to be secondary to the development of cerebral edema possibly due to urea removal during dialysis and from a decreased in pH in the cerebral intracelluar environment
==Clinical Features==
*Signs and symptoms develop during or after dialysis or during renal replacement therapy, usually self limited  but can occasionally progress
*Headache
*Nausea
*Visual disturbances
*Asterixis
*Altered mental staus
*Seizures
*Coma
*Muscle Cramps
==Differential Diagonsis==
*[[Hypoglycemia]]
*[[Hyponatremia]]
*[[Hypocalcemia]]
*[[Uremia]]
*Intracranial Bleed
*[[Hypertensive Emergency]]
*[[Stroke]]
*Supratheurapeutic Medication Effects
*PRES
==Evaluation==
*Clinical Diagonosis
*Bedside Glucose
*CBC
*Chem-10
*Liver Panel
*CT Brain


==Management==
==Management==
Line 96: Line 92:
==Disposition==
==Disposition==
*Most cases can be discharged with followup  
*Most cases can be discharged with followup  
==See Also==
*[[Dialysis complications]]


==References==
==References==
<references/>
<references/>
*Mailloux L, et al. Dialysis Dysequilibrium Syndrome.  UpToDate. Waltham, Mass.: UpToDate; 2017. www.uptodate.com. Accessed April 13, 2017.


[[Category:Renal]]
[[Category:Renal]]
[[Category:Neurology]]
[[Category:Neurology]]

Revision as of 10:01, 27 April 2017

Background

  • Dialysis Disequilibrium Syndrome (DDS) is a rare clinical syndrome occurring at end of dialysis or the beginning of continuous renal replacement therapy
    • Occurs most commonly during initial hemodialysis or during hypercatabolic states
  • Large and rapid solute clearance creates an osmotic gradient which can precipitate cerebral edema [1]
    • Pre-dialysis urea in CSF lower than in blood[2]
    • Post-dialysis urea in CSF higher, setting up osmotic gradient for water into CNS
    • More uremic patients pre-dialysis at higher risk


  • Characterized by neurological symptoms that is thought to be secondary to cerebral edema affecting dialysis patients
  • Tends to occur in patients who are initially started on dialysis, particularly with high initial BUN
  • Symptoms are thought to be secondary to the development of cerebral edema possibly due to urea removal during dialysis and from a decreased in pH in the cerebral intracelluar environment

Clinical Features

  • Headache
  • Disorientation
  • Nausea and vomiting
  • Restlessness
  • Can progress to seizure, coma & death [3]


  • Signs and symptoms develop during or after dialysis or during renal replacement therapy, usually self limited but can occasionally progress
  • Headache
  • Nausea
  • Visual disturbances
  • Asterixis
  • Altered mental staus
  • Seizures
  • Coma
  • Muscle Cramps

Differential Diagnosis

Dialysis Complications


Other

Evaluation

  • Clinical Diagonosis
  • Bedside Glucose
  • CBC
  • Chem-10
  • Liver Panel
  • CT Brain

Workup

  • Diagnosis suggested by development of neurologic symptoms associated with dialysis, however DDS is a diagnosis of exclusion (rule out SDH, CVA).


Management

Prevention

  • Response to treatment is typically poor, so preventive measures are important[3]
  • Add an osmotic agent to mitigate the osmotic gradient
    • Elevate the sodium concentration in the diasylate[5]
    • Elevate the glucose concentration in the diasylate (717 mg/dl) or add IV mannitol (1g/kg)[6]
  • Consider hemofiltration rather than hemodialysis[7]

Treatment

  • The mainstay of treatment is ICP reduction[3]
  • Symptomatic management for mild symptoms (nausea, headache, restlessness)
  • Symptoms are self-limiting and typically resolve within several hours


Management

  • Supportive in most cases
  • Limit the rate of urea removal during first few session of dialysis to prevent dysequilibrium syndrome
  • For severe symptoms such as seizure, consider stopping dialysis

Disposition

  • Most cases can be discharged with followup

See Also

References

  1. Silver SM. et al. Dialysis disequilibrium syndrome (DDS) in the rat: role of the "reverse urea effect". Kidney Int. 1992;42(1):161-6. Pubmed
  2. Zepeda-Orozco D and Quigley R. Dialysis disequilibrium syndrome. Pediatr Nephrol. 2012 Dec; 27(12): 2205–2211.
  3. 3.0 3.1 3.2 3.3 Zepeda-orozco D. et al. Dialysis disequilibrium syndrome. Pediatr Nephrol. 2012;27(12):2205-11.Pubmed
  4. Mahoney CA. et al. Uremic encephalopathies: clinical, biochemical, and experimental features. Am J Kidney Dis. 1982;2(3):324-36. Pubmed
  5. Port FK. et al. Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate. Kidney Int. 1973;3(5):327-33.Pubmed
  6. Rodrigo F. et al. Osmolality changes during hemodialysis. Natural history, clinical correlations, and influence of dialysate glucose and intravenous mannitol. Ann Intern Med. 1977;86(5):554-61. Pubmed
  7. Kishimoto T. et al. Superiority of hemofiltration to hemodialysis for treatment of chronic renal failure: comparative studies between hemofiltration and hemodialysis on dialysis disequilibrium syndrome. Artif Organs. 1980;4(2):86-93. Pubmed